Loading stock data…
OM
$4.36+0.09 (+2.11%)
Market ClosedLast close May 1
Outset Medical, Inc., a medical technology company, engages in the development of a hemodialysis system for hemodialysis in the United States.
Historical Price
Price (Candle)
50-Day SMA
200-Day SMA
Whystock Brain
The Narrative
Outset Medical, Inc. in the Healthcare sector is trading at $4.36. The stock is currently near its 52-week low of $3.00, remaining 47.8% below its 200-day moving average. Technical signals show neutral RSI of 52 and bearish MACD signal, explaining why OM maintains its current current market pressure. The Whystock Score of 15/100 signals elevated caution as indicators diverge.
Ecosystem Influences
Neutral momentum (RSI 52) — price action in range
Long-term trend bearish (Price vs 200-day SMA)
Macro-economic sensitivity to interest rate and inflation shifts
Loading Financials...
Peer Comparison
JNJUNHPFE
Whystock Valuation Model
Whystock fair value is estimated using a trailing P/E model adjusted for return on equity: Fair P/E = 18 + (ROE × 20). Fair Value = (Current Price ÷ Trailing P/E) × Fair P/E. A base P/E of 18 represents a typical market multiple, scaled upward for companies that earn high returns on equity. The result is a theoretical "normalised" price — not a price target or investment advice. Large deviations are common for high-growth or loss-making companies.
Current Price$4.36
Potential Upside
5%
Whystock Fair Value$4.58
Price
UndervaluedFair ValueOvervalued
Simplified model based on P/E and ROE. Not a substitute for full valuation analysis. Data may be delayed. See our Terms.
Fundamentals
Outset Medical, Inc., a medical technology company, engages in the development of a hemodialysis system for hemodialysis in the United States. The company provides Tablo Hemodialysis System, a compact console with integrated water purification, on-de...
Market Cap
Total dollar market value of a company's outstanding shares of stock (Price * Shares).
$83.32M
P/E Ratio
Priced for growth. Investors expect sustained double-digit expansion.
-
Beta
High-beta play. Expect amplified moves vs. the broad market.
1.96
Div Yield
Low to zero yield. Return is entirely dependent on price appreciation.
0.00%
ROE
Average efficiency. Growth may require heavy reinvestment.
-64.32%
Volume
Today's trading volume
133,530
Recent News
Analyst Sentiment on Outset Medical (OM) Remains Strong Following Q4 Results
Outset Medical, Inc. (NASDAQ:OM) is one of the 7 most volatile stocks under $5 for day trading. On February 12, 2026, Outset Medical, Inc. (NASDAQ:OM) shares received fresh support from analysts despite a decline in price targets after fourth-quarter results that largely met expectations. After the company provided what it considered to be a realistic […]
US$10.50: That's What Analysts Think Outset Medical, Inc. (NASDAQ:OM) Is Worth After Its Latest Results
There's been a major selloff in Outset Medical, Inc. ( NASDAQ:OM ) shares in the week since it released its annual...
Outset Medical, Inc. Q4 2025 Earnings Call Summary
Moby summary of Outset Medical, Inc.'s Q4 2025 earnings call
Outset Medical Inc (OM) Q4 2025 Earnings Call Highlights: Strategic Advances and Financial ...
Outset Medical Inc (OM) reports FDA clearance for its NextGen Tableau, revenue growth, and improved gross margins, despite challenges in product revenue and sales cycles.
Outset Medical Q4 Earnings Call Highlights
Outset Medical (NASDAQ:OM) highlighted a year of operational progress, continued gross margin expansion, and an upcoming product launch during its fourth-quarter 2025 earnings call, as management emphasized cost reductions alongside investments aimed at extending the company’s technology and service